Table of Contents Author Guidelines Submit a Manuscript
International Journal of Alzheimer’s Disease
Volume 2011, Article ID 484021, 6 pages
http://dx.doi.org/10.4061/2011/484021
Research Article

Adenosine A2A Receptor and IL-10 in Peripheral Blood Mononuclear Cells of Patients with Mild Cognitive Impairment

Dipartimento di Medicina Interna, Università degli Studi di Milano & Unita di Geriatria, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Pace 9, 20122 Milano, Italy

Received 31 December 2010; Revised 18 February 2011; Accepted 7 March 2011

Academic Editor: A. P. Hudson

Copyright © 2011 Beatrice Arosio et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Haskó, M. V. Sitkovsky, and C. Szabó, “Immunomodulatory and neuroprotective effects of inosine,” Trends in Pharmacological Sciences, vol. 25, no. 3, pp. 152–157, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. G. Haskó, J. Linden, B. Cronstein, and P. Pacher, “Adenosine receptors: therapeutic aspects for inflammatory and immune diseases,” Nature Reviews Drug Discovery, vol. 7, no. 9, pp. 759–770, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. B. B. Fredholm, A. P. Ijzerman, K. A. Jacobson, K. N. Klotz, and J. Linden, “International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors,” Pharmacological Reviews, vol. 53, no. 4, pp. 527–552, 2001. View at Google Scholar · View at Scopus
  4. B. B. Fredholm, G. Arslan, L. Halldner, B. Kull, G. Schulte, and W. Wasserman, “Structure and function of adenosine receptors and their genes,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 362, no. 4-5, pp. 364–374, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. A. A. Erdmann, Z. G. Gao, U. Jung et al., “Activation of Th1 and Tc1 cell adenosine A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo,” Blood, vol. 105, no. 12, pp. 4707–4714, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. C. M. Lappas, J. M. Rieger, and J. Linden, “A adenosine receptor induction inhibits IFN-γ production in murine CD4 T cells,” Journal of Immunology, vol. 174, no. 2, pp. 1073–1080, 2005. View at Google Scholar · View at Scopus
  7. C. M. Lappas, G. W. Sullivan, and J. Linden, “Adenosine AA agonists in development for the treatment of inflammation,” Expert Opinion on Investigational Drugs, vol. 14, no. 7, pp. 797–806, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. P. M. Canas, L. O. Porciúncula, G. M. A. Cunha et al., “Adenosine A receptor blockade prevents synaptotoxicity and memory dysfunction caused by β-amyloid peptides via p38 mitogen-activated protein kinase pathway,” Journal of Neuroscience, vol. 29, no. 47, pp. 14741–14751, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. B. Csóka and G. Haskó, “Adenosine, inflammation pathways and therapeutic challenges,” Joint Bone Spine, vol. 78, no. 1, pp. 4–6, 2011. View at Publisher · View at Google Scholar · View at PubMed
  10. T. Wyss-Coray, “Inflammation in Alzheimer disease: driving force, bystander or beneficial response?” Nature Medicine, vol. 12, no. 9, pp. 1005–1015, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. H. W. Querfurth and F. M. LaFerla, “Alzheimer's disease,” The New England Journal of Medicine, vol. 362, no. 4, pp. 329–344, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. E. Tarkowski, K. Blennow, A. Wallin, and A. Tarkowski, “Intracerebral production of tumor necrosis factor-α, a local neuroprotective agent, in Alzheimer disease and vascular dementia,” Journal of Clinical Immunology, vol. 19, no. 4, pp. 223–230, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Tarkowski, A. M. Liljeroth, A. Nilsson, L. Minthon, and K. Blennow, “Decreased levels of intrathecal interleukin 1 receptor antagonist in Alzheimer's disease,” Dementia and Geriatric Cognitive Disorders, vol. 12, no. 5, pp. 314–317, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Bermejo, S. Martín-Aragón, J. Benedí et al., “Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease,” Immunology Letters, vol. 117, no. 2, pp. 198–202, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. K. Bonotis, E. Krikki, V. Holeva, C. Aggouridaki, V. Costa, and S. Baloyannis, “Systemic immune aberrations in Alzheimer's disease patients,” Journal of Neuroimmunology, vol. 193, no. 1-2, pp. 183–187, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. F. Licastro, E. Porcellini, C. Caruso, D. Lio, and E. H. Corder, “Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation,” Neurobiology of Aging, vol. 28, no. 11, pp. 1637–1643, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. D. Lio, F. Licastro, L. Scola et al., “Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease,” Genes and Immunity, vol. 4, no. 3, pp. 234–238, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. B. Dubois, H. H. Feldman, C. Jacova et al., “Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria,” Lancet Neurology, vol. 6, no. 8, pp. 734–746, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. R. C. Petersen, “Mild cognitive impairment as a diagnostic entity,” Journal of Internal Medicine, vol. 256, no. 3, pp. 183–194, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. M. Zanetti, C. Ballabio, C. Abbate, C. Cutaia, C. Vergani, and L. Bergamaschini, “Mild cognitive impairment subtypes and vascular dementia in community-dwelling elderly people: a 3-year follow-up study,” Journal of the American Geriatrics Society, vol. 54, no. 4, pp. 580–586, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. S. A. Miller, D. D. Dykes, and H. F. Polesky, “A simple salting out procedure for extracting DNA from human nucleated cells,” Nucleic Acids Research, vol. 16, no. 3, p. 1215, 1988. View at Google Scholar · View at Scopus
  22. B. Arosio, D. Trabattoni, L. Galimberti et al., “Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease,” Neurobiology of Aging, vol. 25, no. 8, pp. 1009–1015, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. P. Chomczynski and N. Sacchi, “The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on,” Nature Protocols, vol. 1, no. 2, pp. 581–585, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2T method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. U. K. Laemmli, “Cleavage of structural proteins during the assembly of the head of bacteriophage T4,” Nature, vol. 227, no. 5259, pp. 680–685, 1970. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Dittmer and J. Dittmer, “β-Actin is not a reliable loading control in Western blot analysis,” Electrophoresis, vol. 27, no. 14, pp. 2844–2845, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. P. P. Singh, M. Singh, and S. S. Mastana, “APOE distribution in world populations with new data from India and the UK,” Annals of Human Biology, vol. 33, no. 3, pp. 279–308, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. D. J. Berlau, M. M. Corrada, E. Head, and C. H. Kawas, “ApoE ε2 is associated with intact cognition but increased Alzheimer pathology in the oldest old,” Neurology, vol. 72, no. 9, pp. 829–834, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. G. Bu, “Apolipoprotein e and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy,” Nature Reviews Neuroscience, vol. 10, no. 5, pp. 333–344, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. J. Kim, J. M. Basak, and D. M. Holtzman, “The Role of Apolipoprotein E in Alzheimer's Disease,” Neuron, vol. 63, no. 3, pp. 287–303, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. J. L. Albasanz, S. Perez, M. Barrachina, I. Ferrer, and M. Martín, “Up-regulation of adenosine receptors in the frontal cortex in Alzheimer's disease,” Brain Pathology, vol. 18, no. 2, pp. 211–219, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. V. H. Perry, C. Cunningham, and C. Holmes, “Systemic infections and inflammation affect chronic neurodegeneration,” Nature Reviews Immunology, vol. 7, no. 2, pp. 161–167, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. M. J. Engelhart, M. I. Geerlings, J. Meijer et al., “Inflammatory proteins in plasma and the risk of dementia: the rotterdam study,” Archives of Neurology, vol. 61, no. 5, pp. 668–672, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. H. Akiyama, S. Barger, S. Barnum et al., “Inflammation and Alzheimer's disease,” Neurobiology of Aging, vol. 21, no. 3, pp. 383–421, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. L. F. Lue, L. Brachova, W. H. Civin, and J. Rogers, “Inflammation, Aβ deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration,” Journal of Neuropathology and Experimental Neurology, vol. 55, no. 10, pp. 1083–1088, 1996. View at Google Scholar · View at Scopus
  36. S. Magaki, C. Mueller, C. Dickson, and W. Kirsch, “Increased production of inflammatory cytokines in mild cognitive impairment,” Experimental Gerontology, vol. 42, no. 3, pp. 233–240, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. B. Arosio, L. Mastronardi, C. Vergani, and G. Annoni, “Intereleukin-10 promoter polymorphism in mild cognitive impairment and in its clinical evolution,” International Journal of Alzheimer's Disease, vol. 2010, Article ID 854527, 5 pages, 2010. View at Publisher · View at Google Scholar · View at PubMed
  38. D. Lio, L. Scola, A. Crivello et al., “Gender-specific association between—1082 IL-10 promoter polymorphism and longevity,” Genes and Immunity, vol. 3, no. 1, pp. 30–33, 2002. View at Google Scholar